In addition to the Chinese population, lower and middle income countries in Latin America and Southeast Asia have relied at least in part on Chinese-developed vaccines for their mass immunisations. Photo: Shutterstock Images In addition to the Chinese population, lower and middle income countries in Latin America and Southeast Asia have relied at least in part on Chinese-developed vaccines for their mass immunisations. Photo: Shutterstock Images
In addition to the Chinese population, lower and middle income countries in Latin America and Southeast Asia have relied at least in part on Chinese-developed vaccines for their mass immunisations. Photo: Shutterstock Images

WHO group backs third Covid-19 shot for elderly vaccinated with Sinovac or Sinopharm

  • SAGE says extra dose is not a booster shot but an extension of the main vaccination course
  • Recommendation is a challenge for governments and could affect tens of millions of older adults in China alone, says New York-based analyst

Topic |   Coronavirus vaccine
In addition to the Chinese population, lower and middle income countries in Latin America and Southeast Asia have relied at least in part on Chinese-developed vaccines for their mass immunisations. Photo: Shutterstock Images In addition to the Chinese population, lower and middle income countries in Latin America and Southeast Asia have relied at least in part on Chinese-developed vaccines for their mass immunisations. Photo: Shutterstock Images
In addition to the Chinese population, lower and middle income countries in Latin America and Southeast Asia have relied at least in part on Chinese-developed vaccines for their mass immunisations. Photo: Shutterstock Images
READ FULL ARTICLE